Prolong use of gastroesophageal reflux medications raises risk of dementia, says study

Recent research published in the Neurology journal of the American Academy of Neurology has raised concerns about a potential correlation between long-term usage of proton pump inhibitors (PPIs) and an increased risk of dementia. The study, led by Dr. Kamakshi Lakshminarayan from the University of Minnesota School of Public Health, sheds light on the need for further investigation into the relationship between these commonly used acid reflux medications and cognitive health.

Understanding Acid Reflux and Proton Pump Inhibitors:

Acid reflux or gastroesophageal disease, a condition where stomach acid flows into the esophagus, is a prevalent issue that can lead to discomfort and complications like heartburn, ulcers, and gastroesophageal reflux disease (GERD). Proton pump inhibitors are frequently prescribed to manage acid reflux by inhibiting the production of stomach acid. While these drugs effectively alleviate symptoms, concerns have been raised regarding their potential long-term consequences.

The Study and its Findings:

The study involved 5,712 participants aged 45 and older, without pre-existing dementia, and tracked them for an average of 5.5 years. Among the participants, 26% had taken acid reflux drugs, and they were categorized into four groups based on their usage duration. The findings revealed that individuals who had been using PPIs for more than 4.4 years were associated with a 33% higher risk of developing dementia compared to those who had never taken the drugs. However, no elevated risk of dementia was observed among individuals who used the medications for shorter durations.

Implications and Considerations:

While this study establishes a correlation between long-term PPI use and dementia risk, it is important to note that it does not definitively prove causation. The researchers suggest that further investigations are needed to comprehensively understand the potential mechanisms underlying this relationship. Additionally, the study's limitations, such as reliance on annual medication use reporting and the inability to assess over-the-counter PPI usage, warrant cautious interpretation of the results.

Expert Insights and Recommendations:

Dr. Lakshminarayan emphasizes the importance of patient-doctor communication for individuals who rely on acid reflux medications. She highlights the need for tailored treatment approaches, as discontinuing PPIs abruptly can lead to worsening symptoms. Maintaining a healthy lifestyle, including managing weight, avoiding late meals, and making dietary adjustments, could also help manage acid reflux without long-term medication use.

While this research contributes to the growing body of knowledge, more in-depth studies are required to establish a clearer understanding of the relationship. In the meantime, individuals using PPIs are advised to consult their healthcare providers before making any changes to their treatment plans, ensuring the best course of action for their acid reflux management.